These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 7508049)

  • 1. Endothelium-derived bradykinin: implications for angiotensin-converting enzyme-inhibitor therapy.
    Busse R; Fleming I; Hecker M
    J Cardiovasc Pharmacol; 1993; 22 Suppl 5():S31-6. PubMed ID: 7508049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-converting enzyme inhibitors unmask endogenous kinin production by bovine coronary artery endothelium.
    Hecker M; Bara AT; Busse R
    Eur Heart J; 1993 Nov; 14 Suppl I():161-3. PubMed ID: 8293768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Converting enzyme inhibitor-stimulated formation of nitric oxide and prostacyclin in endothelial cells from bovine aorta is mediated by endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH
    Agents Actions Suppl; 1992; 38 ( Pt 3)():196-200. PubMed ID: 1334350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of endothelial autacoid formation by inhibitors of angiotensin-converting enzyme.
    Hecker M; Benzing T; Busse R
    Agents Actions Suppl; 1992; 38 ( Pt 3)():163-70. PubMed ID: 1281378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relaxation of isolated coronary arteries by angiotensin-converting enzyme inhibitors: role of endothelium-derived kinins.
    Hecker M; Bara AT; Busse R
    J Vasc Res; 1993; 30(5):257-62. PubMed ID: 8399986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells.
    Wiemer G; Popp R; Schölkens BA; Gögelein H
    Brain Res; 1994 Feb; 638(1-2):261-6. PubMed ID: 7515323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of endothelial prostacyclin and nitric oxide in peripheral and pulmonary circulation.
    Gryglewski RJ; Chłopicki S; Uracz W; Marcinkiewicz E
    Med Sci Monit; 2001; 7(1):1-16. PubMed ID: 11208485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
    Auch-Schwelk W; Bossaller C; Claus M; Graf K; Gräfe M; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S62-7. PubMed ID: 1282632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation by ACE inhibitors of the dilator response to bradykinin in the coronary microcirculation: interaction at the receptor level.
    Hecker M; Pörsti I; Bara AT; Busse R
    Br J Pharmacol; 1994 Jan; 111(1):238-44. PubMed ID: 8012702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin.
    Wiemer G; Schölkens BA; Becker RH; Busse R
    Hypertension; 1991 Oct; 18(4):558-63. PubMed ID: 1655653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local regulation of vascular tone by bradykinin and angiotensin converting enzyme inhibitors.
    Auch-Schwelk W; Kuchenbuch C; Claus M; Walther B; Bossaller C; Friedel N; Graf K; Gräfe M; Fleck E
    Eur Heart J; 1993 Nov; 14 Suppl I():154-60. PubMed ID: 8293767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D; Dechaux E; Dowell FJ; Maclour J; Samuel JL; Lévy BI; Michel JB
    Br J Pharmacol; 1997 May; 121(1):83-90. PubMed ID: 9146891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of converting enzyme inhibition on endothelial bradykinin metabolism and endothelium-dependent vascular relaxation.
    Bossaller C; Auch-Schwelk W; Gräfe M; Graf K; Baumgarten C; Fleck E
    Agents Actions Suppl; 1992; 38 ( Pt 3)():171-7. PubMed ID: 1334349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelium-derived bradykinin is responsible for the increase in calcium produced by angiotensin-converting enzyme inhibitors in human endothelial cells.
    Busse R; Lamontagne D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):126-9. PubMed ID: 1663586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of endothelium-dependent relaxations to bradykinin by angiotensin I converting enzyme inhibitors in canine coronary artery involves both endothelium-derived relaxing and hyperpolarizing factors.
    Mombouli JV; Illiano S; Nagao T; Scott-Burden T; Vanhoutte PM
    Circ Res; 1992 Jul; 71(1):137-44. PubMed ID: 1318793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X; Recchia FA; Bernstein R; Xu X; Nasjletti A; Hintze TH
    J Pharmacol Exp Ther; 1999 Feb; 288(2):742-51. PubMed ID: 9918584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.